Naltrexone

What Is Naltrexone (Especially Low-Dose)?

Naltrexone is an opioid receptor antagonist—it blocks mu-opioid receptors in the brain and body. At standard/high doses (50–100 mg), it fully blocks opioid effects and is FDA-approved for alcohol/opioid dependence treatment. At low dose (typically 1.5–4.5 mg, often called LDN), it only briefly occupies receptors (a few hours), triggering a compensatory rebound increase in endorphins and enkephalins. This temporary blockade and rebound effect modulates immune function, reward pathways, and inflammation without causing dependence or significant side effects in most people.

 

How Does Naltrexone Work?

At low dose, naltrexone creates a short-lived “pulse” that shifts multiple systems in helpful ways:

• For Weight Loss & Appetite Control Blocks mu-opioid receptors in the brain’s reward centers , reducing the intense “pleasure hit” from palatable, high-carb, or sugary foods. This dampens hedonic hunger and cravings. The rebound endorphin increase helps normalize appetite regulation and may indirectly improve insulin sensitivity and leptin signaling.

• For Autoimmune Inflammation & Pain Temporary receptor blockade (lasting only hours) upregulates endogenous opioid production (endorphins/enkephalins) and modulates immune cells—particularly T-regulatory cells and glial cells in the central nervous system. This shifts the immune response toward anti-inflammatory pathways, reduces pro-inflammatory cytokines, and calms overactive microglia. The result is often decreased chronic pain, reduced flare frequency, and lower systemic inflammation.

• In simple terms: Low-dose naltrexone briefly “tricks” the body into ramping up its own feel-good chemicals while dialing down immune overdrive and reward-driven behaviors—helping with both cravings and chronic inflammation/pain.

​​​

Potential Benefits

 Weight Loss & Craving Control

When used as part of a comprehensive plan (nutrition, stress management, targeted therapies), low-dose naltrexone is most commonly valued for:

• Weight Loss & Craving Control

• Reduces cravings for sweets, carbs, and comfort foods

• Decreases emotional/stress eating and “food addiction” patterns

• May support 5–10% body weight reduction over 6–12 months (strongest when combined with bupropion, as in Contrave studies, plus diet and exercise)

• Helps address leptin resistance and hedonic hunger without stimulant-like side effects​

• ​

Autoimmune, Inflammatory & Pain Support

• Reduced flare frequency and severity in conditions such as Hashimoto’s thyroiditis, rheumatoid arthritis, fibromyalgia, Crohn’s disease, multiple sclerosis, or complex regional pain syndrome (based on observational reports and small studies)

• Lowered chronic pain, especially central/nerve-related or fibromyalgia-type pain

• Improved fatigue, brain fog, and overall quality of life in inflammatory states

• Calms glial cell activation, helping reduce neuroinflammation and “sickness behavior”

Many people report subtle but meaningful changes — fewer cravings and more control around food, plus a noticeable drop in daily pain/inflammation — after 4–12 weeks of consistent low-dose use.